Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 55.77
-0.43 (-0.77%)
Apr 28, 2026, 4:00 PM EDT
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 25.94 billion as of April 28, 2026. Its market cap has increased by 26.77% in one year.
Market Cap
25.94B
Enterprise Value
25.25B
Revenue
801.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.77
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 25.94B, an increase of 57.80%. That is a compound annual growth rate of 10.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 25.94B | -2.34% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Livzon Pharmaceutical Group | 26.70B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 27.05B |
| Hubei Jumpcan Pharmaceutical | 24.61B |
| Shijiazhuang Yiling Pharmaceutical | 27.85B |
| Kangmei Pharmaceutical | 23.79B |
| Chengdu Kanghong Pharmaceutical Group | 23.53B |
| Zhejiang Huahai Pharmaceutical | 23.43B |
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 22.23B |